Cardiac channelopathies

Nature

Volumn 415, Issue 6868, 2002, Pages 213-218

  Marbán, Eduardo ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; DRUG THERAPY; GENETIC ENGINEERING; IONS;

CARDIAC EXCITABILITY;

CARDIOLOGY;

ANTIBIOTIC AGENT; DOFETILIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; ION CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT;

DISEASE;

ARTIFICIAL HEART PACEMAKER; DEFIBRILLATOR; DRUG TARGETING; GENE THERAPY; GENETIC DISORDER; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE EXCITABILITY; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; REVIEW; SUDDEN DEATH;

ANIMALS; ARRHYTHMIA; ELECTROCARDIOGRAPHY; FORECASTING; GENE THERAPY; HUMANS; ION CHANNELS;

EID: 0037049999     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/415213a     Document Type: Review

References (64)

1. Molecular properties of sodium and calcium channels
2. Voltage-gated and inwardly rectifying potassium channels
3. Sodium-calcium exchange: A molecular perspective
4. Structure and function of voltage-gated sodium channels
5. Early afterdepolarizations in cardiac myocytes: Mechanism and rate dependence
6. KCNQ channels: Physiology, pathophysiology, and pharmacology
7. Characteristics of transient outward current in human ventricular myocytes from patients with terminal heart failure
8. Manipulation of cellular excitability by cell fusion: Effects of rapid introduction of transient outward K current on the guinea pig action potential
9. i transients in single rabbit heart Purkinje cells
10. +
11. Molecular basis of transient outward potassium current downregulation in human heart failure: A decrease in Kv 4.3 mRNA correlates with a reduction in current density
12. Regional differences in current density and rate-dependent properties of the transient outward current in subepicardial and subendocardial myocytes of human left ventricle
13. Molecular dissection of cardiac repolarization by in vivo Kv 4.3 gene transfer
14. Modeling the cellular basis of altered excitation-contraction coupling in heart failure
15. Molecular and cellular mechanisms of cardiac arrhythmias
16. A novel cardiac potassium channel that is active and conductive at depolarized potentials
17. + channels
18. + channel (cTBAK-1)
19. A dynamic model of the cardiac ventricular action potential. I. Simulations of ionic currents and concentration changes
20. The electrical constants of Purkinje fibres
21. ATP-sensitive potassium channel modulation of the guinea pig ventricular action potential and contraction
22. Mechanisms of arrhythmogenic delayed and early afterdepolarizations in ferret ventricular muscle
23. Torsades de pointes and early afterdepolarizations
24. Connexin expression and turnover: Implications for cardiac excitability
25. Purkinje-muscle reentry as a mechanism of polymorphic ventricular arrhythmias in a 3-dimensional model of the ventricles
26. Cellular mechanisms for cardiac arrhythmias
27. Mechanisms underlying ventricular tachycardia and its transition to ventricular fibrillation in the structurally normal heart
28. Congenital and acquired long QT syndrome
29. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome
30. Dysfunction of delayed rectifier potassium channels in an inherited cardiac arrhythmia
31. + channel-linked long-QT syndrome
32. Distinct gene-specific mechanisms of arrhythmia revealed by cardiac gene transfer of two long QT disease genes, HERG and KCNE1
33. Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2
34. Genotype-phenotype correlation in the long-QT syndrome: Gene-specific triggers for life-threatening arrhythmias
35. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome
36. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation
37. The Brugada syndrome: Ionic basis and arrhythmia mechanisms
38. Human SCN 5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome
39. Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent
40. Action potential propagation in inhomogeneous cardiac tissue: Safety factor considerations and ionic mechanism
41. Cardiac conduction defects associate with mutations in SCN 5A
42. A sodium-channel mutation causes isolated cardiac conduction disease
43. + channel
44. Heart failure: The electrophysiologic connection
45. + currents in isolated human ventricular myocytes from patients with terminal heart failure
46. Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure
47. Beat-to-beat QT interval variability: Novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy
48. 2+ exchanger in end-stage human heart failure
49. Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, II: Model studies
50. Kr potassium channel
51. A structural basis for drug-induced long QT syndrome
52. Female gender is a risk factor for torsades de pointes in an in vitro animal model
53. Inherited long QT syndromes: A paradigm for understanding arrhythmogenesis
54. Pharmacogenetics and drug-induced arrhythmias
55. Kr potassium channels with HERG and is associated with cardiac arrhythmia
56. Molecular interactions between two ]ong long-QT syndrome gene products, HERG and KCNE2, rationalized by in vitro and in silico analysis
57. Genetic and molecular basis of cardiac arrhythmias: Impact on clinical management parts I and II
58. Effects of flecainide in patients with new SCN5A mutation: Mutation-specific therapy for long-QT syndrome?
59. Normalization of ventricular repolarization with flecainide in long QT syndrome patients with SCN5A:DeltaKPQ mutation
60. Genetically defined therapy of inherited long-QT syndrome. Correction of abnormal repolarization by potassium
61. + channel opener in the LQT1 form of congenital long-QT syndrome
62. Reversal of potassium channel deficiency in cells from failing hearts by adenoviral gene transfer: A prototype for gene therapy for disorders of cardiac excitability and contractility
63. Overexpression of a human potassium channel suppresses cardiac hyperexcitability in rabbit ventricular myocytes
64. Focal modification of electrical conduction in the heart by viral gene transfer